Literature DB >> 17338883

[Atherosclerosis as a systemic disease].

Carlos Lahoz1, José M Mostaza.   

Abstract

Atherosclerosis is a widespread, chronic progressive disease that mainly involves medium-sized arteries. Clinically, it can become apparent as ischemic heart disease, cerebrovascular disease, or peripheral arterial disease. In Spain, atherosclerosis is responsible for 124,000 deaths each year. Despite the trend towards a reduction in the aged-adjusted mortality rate for cardiovascular disease, the public health burden is expected to increase. The risk factors are the same for all affected vascular beds, regardless of location, and can be classified as either causal, conditional or predisposing. The presence of atherosclerosis in a particular vascular bed is frequently associated with disease in other vascular territories. Risk assessment tables, inflammatory markers, imaging, and the ankle-brachial index can help in identifying subclinical atherosclerosis. Given the systemic nature of the disease, treatment with statins, antiplatelet agents and angiotensin-converting enzyme inhibitors have consistently proven beneficial, irrespective of the vascular bed affected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17338883

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  14 in total

1.  Reduction of heat shock protein antibody levels by statin therapy.

Authors:  María C Guisasola; Elena Dulín; Jesús Almendral; Pedro García-Barreno
Journal:  Lipids       Date:  2008-11-26       Impact factor: 1.880

2.  Remodeling of the thoracic aorta after bone marrow cell transplantation.

Authors:  Alyne Felix; Nemesis Monteiro; Vinícius Novaes Rocha; Genilza Oliveira; Alan Cesar Moraes; Cherley Andrade; Ana Lucia Nascimento; Laís de Carvalho; Alessandra Thole; Jorge Carvalho
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Link between angiographic extent and severity of coronary artery disease and degree of sensorineural hearing loss.

Authors:  A F Erkan; G K Beriat; B Ekici; C Doğan; S Kocatürk; H F Töre
Journal:  Herz       Date:  2013-12-21       Impact factor: 1.443

4.  Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study.

Authors:  Ashleigh O Gibson; Michael J Blaha; Martinson K Arnan; Ralph L Sacco; Moyses Szklo; David M Herrington; Joseph Yeboah
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-10

5.  Extracellular heat shock protein 70 (HSPA1A) and classical vascular risk factors in a general population.

Authors:  Elena Dulin; Pedro García-Barreno; Maria C Guisasola
Journal:  Cell Stress Chaperones       Date:  2010-05-20       Impact factor: 3.667

6.  Carotid Plaque Composition Assessed by CT Predicts Subsequent Cardiovascular Events among Subjects with Carotid Stenosis.

Authors:  E Choi; E Byun; S U Kwon; N Kim; C H Suh; H Kwon; Y Han; T-W Kwon; Y-P Cho
Journal:  AJNR Am J Neuroradiol       Date:  2021-10-28       Impact factor: 3.825

7.  Meal replacement based on Human Ration modulates metabolic risk factors during body weight loss: a randomized controlled trial.

Authors:  Natalia Elizabeth Galdino Alves; Bárbara Nery Enes; Hércia Stampini Duarte Martino; Rita de Cássia Gonçalves Alfenas; Sônia Machado Rocha Ribeiro
Journal:  Eur J Nutr       Date:  2013-10-29       Impact factor: 5.614

Review 8.  Endothelial dysfunction: the early predictor of atherosclerosis.

Authors:  Mashudu Mudau; Amanda Genis; Amanda Lochner; Hans Strijdom
Journal:  Cardiovasc J Afr       Date:  2012-05       Impact factor: 1.167

Review 9.  Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategies.

Authors:  Marisa Di Pietro; Simone Filardo; Fiorenzo De Santis; Paola Mastromarino; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2014-12-30       Impact factor: 5.923

Review 10.  Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target.

Authors:  Ronodeep Mitra; Gerard Leland O'Neil; Ian Chandler Harding; Ming Jie Cheng; Solomon Arko Mensah; Eno Essien Ebong
Journal:  Curr Atheroscler Rep       Date:  2017-11-10       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.